Abstract
Human adenovirus 36 (Adv36) increases adiposity and is more prevalent in overweight and obese children. Dietary intake in animal models is comparable regardless of Adv36 status. The effects of Adv36 on obesity treatment outcomes have not been clarified. The aim of this study is to investigate the pre-treatment dietary intake and the response to a 4-week inpatient weight management in 184 obese adolescent girls aged 13.0–17.9 years with respect to the presence of Adv36 antibodies. Evaluation of 3-day dietary records did not show any difference in daily intake of energy and essential nutrients between Adv36 antibody positive and negative girls. After the intervention Adv36 positive girls presented with significantly greater decrease of waist circumference (P=0.020), z-score of waist circumference (P=0.024), waist-to-hip ratio (P=0.007) and weight-to-height ratio (P=0.019) compared with Adv36 negative girls. On the contrary, the sum of four skinfolds decreased significantly more in Adv36 negative than in Adv36 positive individuals (P=0.013). Neither body fat percentage nor metabolic and hormonal parameters showed any significant relevance to Adv36 status in response to weight loss intervention. In conclusion, energy restriction in Adv36 antibody positive girls was associated with greater decrease of abdominal obesity and preservation of subcutaneous fat tissue than in those antibody negative.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–2374.
Reinehr T, Widhalm K, l'Allemand D, Wiegand S, Wabitsch M, Holl RW et al. Two-year follow-up in 21,784 overweight children and adolescents with lifestyle intervention. Obesity (Silver Spring) 2009; 17: 1196–1199.
Huelsing J, Kanafani N, Mao J, White NH . Camp jump start: effects of a residential summer weight-loss camp for older children and adolescents. Pediatrics 2010; 125: e884–e890.
Hainer V, Hlavatá K, Gojová M, Kunesová M, Wagenknecht M, Kopský V et al. Hormonal and psychobehavioral predictors of weight loss in response to a short-term weight reduction program in obese women. Physiol Res 2008; 57: S17–S27.
Uysal Y, Wolters B, Knop C, Reinehr T . Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention. Clin Nutr 2014; 33: 620–625.
Atkinson RL, Lee I, Shin HJ, He J . Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 2010; 5: 157–160.
Pasarica M, Shin AC, Yu M, Ou Yang HM, Rathod M, Jen KL et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006; 14: 1905–1913.
Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL . Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000; 24: 989–996.
Vander Wal JS, Huelsing J, Dubuisson O, Dhurandhar NV . An observational study of the association between adenovirus 36 antibody status and weight loss among youth. Obes Facts 2013; 6: 269–278.
Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535–544.
Na HN, Hong YM, Ye MB, Park S, Kim IB, Nam JH . Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver. PLoS One 2014; 9: e114534.
Aldhoon-Hainerová I, Zamrazilová H, Atkinson RL, Dušátková L, Sedláčková B, Hlavatý P et al. Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36. Int J Obes (Lond) 2014; 38: 285–291.
Aldhoon-Hainerová I, Zamrazilová H, Dušátková L, Sedláčková B, Hlavatý P, Hill M et al. Glucose homeostasis and insulin resistance: prevalence, gender differences and predictors in adolescents. Diabetol Metab Syndr 2014; 6: 100.
Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes 2007; 8: 299–306.
Schoeller DA, Thomas D, Archer E, Heymsfield SB, Blair SN, Goran MI et al. Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions. Am J Clin Nutr 2013; 97: 1413–1415.
Lichtman SW, Pisarska K, Berman ER, Pestone M, Dowling H, Offenbacher E et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992; 327: 1893–1898.
Dhurandhar NV, Schoeller D, Brown AW, Heymsfield SB, Thomas D, Sørensen TI et al. Energy balance measurement: when something is not better than nothing. Int J Obes (Lond) 2015; 39: 1109–1113.
Börnhorst C, Bel-Serrat S, Pigeot I, Huybrechts I, Ottavaere C, Sioen I et al. Validity of 24- h recalls in (pre-)school aged children: comparison of proxy-reported energy intakes with measured energy expenditure. Clin Nutr 2014; 33: 79–84.
Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013; 36: 701–707.
Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779–E789.
Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang Z, Dasuri K et al. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 2008; 57: 2321–2331.
Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281–286.
Almgren M, Atkinson R, He J, Hilding A, Hagman E, Wolk A et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One 2012; 7: e41652.
Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402–1409.
Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C et al. AD36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184–190.
Acknowledgements
This study was supported by NT/13792-4 Internal Grant Agency of the Ministry of Health of the Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
RLA is the owner of Obetech, LLC, a company that provides assays for adenoviruses that produce obesity and has several patents for diagnostic assays and vaccines in the area of virus-induced obesity. RLA is a Co-Editor of the International Journal of Obesity. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Zamrazilová, H., Aldhoon-Hainerová, I., Atkinson, R. et al. Adenovirus 36 infection: a role in dietary intake and response to inpatient weight management in obese girls. Int J Obes 39, 1757–1760 (2015). https://doi.org/10.1038/ijo.2015.167
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2015.167
This article is cited by
-
Adenovirus 36 prevalence and association with human obesity: a systematic review
International Journal of Obesity (2021)